Asset Details
Do you wish to reserve the book?
Immune Response, Inflammation, and the Clinical Spectrum of COVID-19
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Immune Response, Inflammation, and the Clinical Spectrum of COVID-19
Do you wish to request the book?
Immune Response, Inflammation, and the Clinical Spectrum of COVID-19
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Immune Response, Inflammation, and the Clinical Spectrum of COVID-19
2020
Overview
The current COVID-19 pandemic began in December 2019 in Wuhan (China) and rapidly extended to become a global sanitary and economic emergency. Its etiological agent is the coronavirus SARS-CoV-2. COVID-19 presents a wide spectrum of clinical manifestations, which ranges from an asymptomatic infection to a severe pneumonia accompanied by multisystemic failure that can lead to a patient's death. The immune response to SARS-CoV-2 is known to involve all the components of the immune system that together appear responsible for viral elimination and recovery from the infection. Nonetheless, such immune responses are implicated in the disease's progression to a more severe and lethal process. This review describes the general aspects of both COVID-19 and its etiological agent SARS-CoV-2, stressing the similarities with other severe coronavirus infections, such as SARS and MERS, but more importantly, pointing toward the evidence supporting the hypothesis that the clinical spectrum of COVID-19 is a consequence of the corresponding variable spectrum of the immune responses to the virus. The critical point where progression of the disease ensues appears to center on loss of the immune regulation between protective and altered responses due to exacerbation of the inflammatory components. Finally, it appears possible to delineate certain major challenges deserving of exhaustive investigation to further understand COVID-19 immunopathogenesis, thus helping to design more effective diagnostic, therapeutic, and prophylactic strategies.
Publisher
Frontiers Media SA,Frontiers Media S.A
Subject
/ Antibodies, Viral - immunology
/ Antibody-Dependent Enhancement - immunology
/ Betacoronavirus - classification
/ Betacoronavirus - immunology
/ Coronavirus Infections - diagnosis
/ Coronavirus Infections - immunology
/ Coronavirus Infections - pathology
/ COVID-19
/ Enzymes
/ Genomes
/ Humans
/ Immunoglobulin A, Secretory - immunology
/ Ligands
/ Middle East respiratory syndrome
/ Pneumonia, Viral - diagnosis
/ Pneumonia, Viral - immunology
/ Pneumonia, Viral - pathology
/ Proteins
/ Severe acute respiratory syndrome coronavirus 2
/ T cells
/ Viruses
